Cargando…

Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs

Cell-based immunotherapies have been selected for the front-line cancer treatment approaches. Among them, CAR-T cells have shown extraordinary effects in hematologic diseases including chemotherapy-resistant acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moghanloo, Ehsan, Mollanoori, Hasan, Talebi, Mohsen, Pashangzadeh, Salar, Faraji, Fatemeh, Hadjilooei, Farimah, Mahmoodzadeh, Habibollah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027274/ https://www.ncbi.nlm.nih.gov/pubmed/33789222 http://dx.doi.org/10.1016/j.tranon.2021.101070

Ejemplares similares

Engineering Next-Generation CAR-T Cells for Better Toxicity Management
por: Andrea, Alain E., et al.
Publicado: (2020)

CAR models: next-generation CAR modifications for enhanced T-cell function
por: Abate-Daga, Daniel, et al.
Publicado: (2016)

CAR-T: What Is Next?
por: Chen, Yi-Ju, et al.
Publicado: (2023)

Engineering the next generation of CAR-NK immunotherapies
por: Biederstädt, Alexander, et al.
Publicado: (2021)

CAR-T cell combination therapy: the next revolution in cancer treatment
por: Al-Haideri, Maysoon, et al.
Publicado: (2022)

Application and Design of Switches Used in CAR
por: Głowacki, Paweł, et al.
Publicado: (2022)

Next frontiers in CAR T-cell therapy
por: Brown, Christine E, et al.
Publicado: (2016)

Situation Awareness Measurement in Remotely Controlled Cars
por: Linkov, Václav, et al.
Publicado: (2021)

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Next generations of CAR-T cells - new therapeutic opportunities in hematology?
por: Tomasik, Jaromir, et al.
Publicado: (2022)

Toxicity and management in CAR T-cell therapy
por: Bonifant, Challice L, et al.
Publicado: (2016)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

Teaching an old dog new tricks: next-generation CAR T cells
por: Tokarew, Nicholas, et al.
Publicado: (2018)

Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy
por: Arndt, Claudia, et al.
Publicado: (2020)

Light‐Controllable Binary Switch Activation of CAR T Cells
por: Kobayashi, Aya, et al.
Publicado: (2022)

Conventional CARs versus modular CARs
por: Feldmann, Anja, et al.
Publicado: (2019)

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
por: Fu, Wenyan, et al.
Publicado: (2019)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

New Policy and Regulations for a Radiology-Oncology Center During the COVID-19 Outbreak in Tehran, Iran
por: Samiee, Sara, et al.
Publicado: (2020)

SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
por: Alcaina, Yago, et al.
Publicado: (2022)

Gene modification strategies for next-generation CAR T cells against solid cancers
por: Tian, Yonggui, et al.
Publicado: (2020)

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
por: Dimitri, Alexander, et al.
Publicado: (2022)

Evaluation of switch-mediated costimulation in trans on universal CAR-T cells (UniCAR) targeting CD123-positive AML
por: Meyer, Jan-Erik, et al.
Publicado: (2021)

Seatbelts in CAR therapy: How Safe Are CARS?
por: Minagawa, Kentaro, et al.
Publicado: (2015)

Motor Cars for Doctors: Cars Suitable for Practitioners
Publicado: (1906)

Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches
por: Duong, MyLinh T., et al.
Publicado: (2018)

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
por: Hawkins, Elizabeth R, et al.
Publicado: (2021)

CAR‐NK cells: the next wave of cellular therapy for cancer
por: Daher, May, et al.
Publicado: (2021)

CAR-NK cell therapy for glioblastoma: what to do next?
por: Xiong, Qi, et al.
Publicado: (2023)

Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
por: Sun, Shangjun, et al.
Publicado: (2018)

CAR T Cell Toxicity: Current Management and Future Directions
por: Yáñez, Lucrecia, et al.
Publicado: (2019)

CERN cars at car sharing point on the Meyrin site
por: Andrade, Rui
Publicado: (2022)

Motor Cars for Doctors: Hints on Buying a Car
Publicado: (1906)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Engineering switchable and programmable universal CARs for CAR T therapy
por: Liu, Delong, et al.
Publicado: (2019)

Universal CARs, universal T cells, and universal CAR T cells
por: Zhao, Juanjuan, et al.
Publicado: (2018)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
por: Arjomandnejad, Motahareh, et al.
Publicado: (2022)

Conditional control of universal CAR T cells by cleavable OFF-switch adaptors
por: Kvorjak, Michael, et al.
Publicado: (2023)

Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors
por: Kvorjak, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pgk1tiha6suo9pc3duhik4p3c1